ARCHIVES

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

Marvin Schneiderman To Retire March 1

February 8, 1980

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

April 2, 1976

In Brief: Mueller, Rosenberg Head AACR; Elion, Schein Presidents Elect; PHS Offers epidemiology Training

May 7, 1982

Susan Weiner Named to HHS Panel

January 17, 2003

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Congress Orders Programs In Nutrition Research; Cancer Act Extension Beefs Up NCI Chief’s Authority

July 12, 1974